Physician profile
Cara Keating
NPI 1982010096
$6,147.24
in general payments reported to CMS, 2019-2025
17 companies · $5,202 in 2025
The $5,202 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $242 · 2023: $248 · 2024: $346 · 2025: $5,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $1,831 · Travel and Lodging: $1,565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $1,830.84 |
| Travel and Lodging | $1,565.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $5,050.28 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $338.30 | 2022-2025 | |
| Boston Scientific Corporation | $157.98 | 2021-2024 | Watchman Access System |
| Scpharmaceuticals INC. | $130.93 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $121.82 | 2022 | |
| Kestra Medical Technology Services, INC. | $77.95 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $48.57 | 2022-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.52 | 2023-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $29.99 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $28.05 | 2023-2024 | Eliquis, Camzyos |
| Lexicon Pharmaceuticals, INC. | $27.54 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $21.57 | 2024 | Arcalyst |
| Novo Nordisk INC | $18.55 | 2023 | Ozempic |
| Esperion Therapeutics, INC. | $17.91 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.64 | 2024 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.89 | 2023 | Repatha |
| Acacia Pharma INC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.